Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 96 | 2023 | 3220 | 6.500 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 18 | 2017 | 555 | 2.630 |
Why?
|
Fatigue | 8 | 2021 | 1550 | 2.270 |
Why?
|
Brain | 101 | 2024 | 27060 | 2.150 |
Why?
|
Magnetic Resonance Imaging | 154 | 2024 | 36362 | 2.100 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 11 | 2023 | 254 | 1.820 |
Why?
|
Atrophy | 31 | 2020 | 1631 | 1.600 |
Why?
|
Nerve Fibers, Myelinated | 11 | 2011 | 952 | 1.300 |
Why?
|
Subtraction Technique | 4 | 2011 | 511 | 0.840 |
Why?
|
Disease Progression | 31 | 2022 | 13484 | 0.830 |
Why?
|
Leukoencephalopathies | 5 | 2019 | 252 | 0.800 |
Why?
|
Medial Forebrain Bundle | 1 | 2021 | 43 | 0.740 |
Why?
|
Anti-Anxiety Agents | 1 | 2023 | 397 | 0.700 |
Why?
|
Imaging, Three-Dimensional | 13 | 2018 | 4063 | 0.700 |
Why?
|
Cognition Disorders | 14 | 2015 | 3975 | 0.700 |
Why?
|
Image Interpretation, Computer-Assisted | 15 | 2019 | 3346 | 0.690 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 6 | 2019 | 242 | 0.660 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2018 | 8967 | 0.650 |
Why?
|
Thalamus | 6 | 2024 | 1043 | 0.560 |
Why?
|
Neurofilament Proteins | 4 | 2022 | 336 | 0.530 |
Why?
|
Gait | 7 | 2011 | 816 | 0.520 |
Why?
|
Image Enhancement | 13 | 2020 | 2882 | 0.510 |
Why?
|
Aging | 15 | 2021 | 8689 | 0.500 |
Why?
|
Cerebrovascular Disorders | 4 | 2013 | 1475 | 0.490 |
Why?
|
Mobility Limitation | 4 | 2013 | 408 | 0.450 |
Why?
|
Longitudinal Studies | 29 | 2020 | 14565 | 0.440 |
Why?
|
Spinal Cord | 6 | 2020 | 1817 | 0.440 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2788 | 0.420 |
Why?
|
Reproducibility of Results | 29 | 2023 | 20078 | 0.420 |
Why?
|
Corpus Callosum | 6 | 2018 | 749 | 0.410 |
Why?
|
Male | 137 | 2023 | 360035 | 0.400 |
Why?
|
Gait Disorders, Neurologic | 2 | 2011 | 240 | 0.390 |
Why?
|
Physicians' Offices | 1 | 2011 | 60 | 0.380 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1248 | 0.380 |
Why?
|
Diffusion Tensor Imaging | 10 | 2018 | 2399 | 0.380 |
Why?
|
Humans | 188 | 2024 | 760437 | 0.370 |
Why?
|
Neuropsychological Tests | 18 | 2016 | 7029 | 0.370 |
Why?
|
Nerve Regeneration | 2 | 2007 | 795 | 0.370 |
Why?
|
Adult | 98 | 2023 | 220781 | 0.370 |
Why?
|
Blood Pressure | 7 | 2019 | 8479 | 0.360 |
Why?
|
Movement Disorders | 3 | 2005 | 459 | 0.360 |
Why?
|
Female | 127 | 2023 | 391875 | 0.350 |
Why?
|
Algorithms | 20 | 2021 | 14002 | 0.340 |
Why?
|
Pattern Recognition, Automated | 4 | 2015 | 996 | 0.340 |
Why?
|
Middle Aged | 82 | 2023 | 220382 | 0.330 |
Why?
|
Interferon-beta | 4 | 2014 | 345 | 0.330 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.330 |
Why?
|
Delirium | 5 | 2019 | 1667 | 0.310 |
Why?
|
Internet | 1 | 2020 | 3092 | 0.310 |
Why?
|
Anisotropy | 5 | 2021 | 1283 | 0.310 |
Why?
|
Anatomy, Artistic | 1 | 2008 | 51 | 0.300 |
Why?
|
Mathematical Computing | 2 | 2006 | 142 | 0.300 |
Why?
|
Corpus Striatum | 1 | 2014 | 1235 | 0.300 |
Why?
|
Disability Evaluation | 13 | 2013 | 1834 | 0.300 |
Why?
|
Medical Illustration | 1 | 2008 | 135 | 0.290 |
Why?
|
Walking | 3 | 2011 | 1199 | 0.280 |
Why?
|
Gadolinium | 7 | 2020 | 960 | 0.280 |
Why?
|
Medulla Oblongata | 1 | 2008 | 248 | 0.280 |
Why?
|
Sensitivity and Specificity | 18 | 2017 | 14661 | 0.270 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2023 | 552 | 0.270 |
Why?
|
Cardiac Output | 1 | 2009 | 837 | 0.270 |
Why?
|
HLA Antigens | 2 | 2010 | 1371 | 0.260 |
Why?
|
Gadolinium DTPA | 4 | 2007 | 823 | 0.260 |
Why?
|
Depression | 4 | 2021 | 8104 | 0.260 |
Why?
|
Artifacts | 8 | 2008 | 1898 | 0.250 |
Why?
|
Macaca mulatta | 2 | 2008 | 2322 | 0.240 |
Why?
|
Information Management | 1 | 2005 | 100 | 0.230 |
Why?
|
Seasons | 1 | 2010 | 1518 | 0.230 |
Why?
|
Statistics as Topic | 3 | 2009 | 2357 | 0.220 |
Why?
|
Hypoxia, Brain | 1 | 2004 | 138 | 0.220 |
Why?
|
Friedreich Ataxia | 2 | 2013 | 77 | 0.210 |
Why?
|
Anxiety | 1 | 2017 | 4558 | 0.200 |
Why?
|
Severity of Illness Index | 18 | 2020 | 15820 | 0.200 |
Why?
|
Essential Tremor | 1 | 2024 | 157 | 0.200 |
Why?
|
Prospective Studies | 23 | 2023 | 54339 | 0.200 |
Why?
|
Nerve Degeneration | 1 | 2006 | 748 | 0.190 |
Why?
|
Cerebellum | 4 | 2018 | 1500 | 0.190 |
Why?
|
Brain Ischemia | 3 | 2016 | 3048 | 0.180 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26063 | 0.180 |
Why?
|
Aged, 80 and over | 26 | 2019 | 58859 | 0.180 |
Why?
|
Models, Neurological | 3 | 2010 | 1765 | 0.180 |
Why?
|
Central Nervous System | 2 | 2006 | 1337 | 0.180 |
Why?
|
Cerebrovascular Circulation | 5 | 2016 | 2728 | 0.180 |
Why?
|
Cerebral Veins | 2 | 2016 | 157 | 0.180 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 924 | 0.180 |
Why?
|
Brain Mapping | 14 | 2016 | 6603 | 0.180 |
Why?
|
Aged | 39 | 2019 | 168840 | 0.170 |
Why?
|
Contrast Media | 7 | 2020 | 5310 | 0.170 |
Why?
|
Cognition | 10 | 2020 | 6973 | 0.170 |
Why?
|
Follow-Up Studies | 21 | 2019 | 39078 | 0.170 |
Why?
|
Immunologic Factors | 5 | 2013 | 1588 | 0.170 |
Why?
|
Memory, Short-Term | 3 | 2023 | 981 | 0.160 |
Why?
|
Aquaporin 4 | 1 | 2019 | 161 | 0.150 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 95 | 0.150 |
Why?
|
Retinal Artery | 1 | 2018 | 109 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 1 | 2004 | 1433 | 0.150 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2010 | 1870 | 0.140 |
Why?
|
Speech | 1 | 2022 | 553 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 390 | 0.140 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 491 | 0.140 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2018 | 0.140 |
Why?
|
Wine | 1 | 2017 | 166 | 0.140 |
Why?
|
Hypertension | 4 | 2019 | 8527 | 0.140 |
Why?
|
Optic Nerve | 1 | 2020 | 572 | 0.140 |
Why?
|
Echo-Planar Imaging | 5 | 2007 | 663 | 0.130 |
Why?
|
Alzheimer Disease | 7 | 2022 | 8579 | 0.130 |
Why?
|
Heart Diseases | 1 | 2009 | 2785 | 0.130 |
Why?
|
Retrospective Studies | 16 | 2023 | 80430 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2019 | 15627 | 0.130 |
Why?
|
Memory Disorders | 2 | 2016 | 1198 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 609 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2002 | 1496 | 0.120 |
Why?
|
Urinary Incontinence | 2 | 2010 | 489 | 0.120 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 263 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2013 | 275 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2006 | 3576 | 0.120 |
Why?
|
Models, Biological | 2 | 2021 | 9462 | 0.120 |
Why?
|
Parietal Lobe | 3 | 2008 | 850 | 0.120 |
Why?
|
Nerve Fibers | 1 | 1998 | 708 | 0.120 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 252 | 0.110 |
Why?
|
Cephalometry | 1 | 2016 | 382 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 2016 | 351 | 0.110 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2568 | 0.110 |
Why?
|
Stereotaxic Techniques | 1 | 1996 | 554 | 0.110 |
Why?
|
Models, Statistical | 5 | 2015 | 5078 | 0.110 |
Why?
|
Predictive Value of Tests | 12 | 2016 | 15257 | 0.110 |
Why?
|
Regression Analysis | 8 | 2015 | 6340 | 0.110 |
Why?
|
Dementia | 1 | 2008 | 2679 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2018 | 6230 | 0.100 |
Why?
|
Organ Size | 5 | 2017 | 2252 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 256 | 0.100 |
Why?
|
Mental Processes | 1 | 2013 | 245 | 0.100 |
Why?
|
HLA-B Antigens | 2 | 2010 | 331 | 0.100 |
Why?
|
Stroke | 3 | 2023 | 9745 | 0.100 |
Why?
|
Theory of Mind | 1 | 2013 | 91 | 0.100 |
Why?
|
Prognosis | 7 | 2016 | 29551 | 0.100 |
Why?
|
Young Adult | 17 | 2017 | 59068 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2004 | 3765 | 0.100 |
Why?
|
Thalamic Nuclei | 1 | 2012 | 111 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 574 | 0.100 |
Why?
|
Brain Diseases | 2 | 2018 | 1544 | 0.100 |
Why?
|
Psychomotor Performance | 2 | 2013 | 1880 | 0.090 |
Why?
|
Software | 4 | 2018 | 4426 | 0.090 |
Why?
|
Skull | 1 | 2016 | 818 | 0.090 |
Why?
|
Drug Substitution | 1 | 2014 | 288 | 0.090 |
Why?
|
Executive Function | 3 | 2019 | 1383 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 39 | 0.090 |
Why?
|
Cohort Studies | 10 | 2019 | 41366 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 5 | 2013 | 17854 | 0.090 |
Why?
|
Temporal Lobe | 2 | 2008 | 1690 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1610 | 0.090 |
Why?
|
Consensus | 2 | 2020 | 3115 | 0.090 |
Why?
|
Caudate Nucleus | 1 | 2012 | 389 | 0.090 |
Why?
|
Head | 1 | 1996 | 924 | 0.090 |
Why?
|
AIDS Dementia Complex | 1 | 2011 | 153 | 0.090 |
Why?
|
Normal Distribution | 2 | 2009 | 272 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2563 | 0.090 |
Why?
|
Reaction Time | 1 | 2016 | 2078 | 0.090 |
Why?
|
Motor Activity | 2 | 2016 | 2710 | 0.090 |
Why?
|
Facial Expression | 1 | 2013 | 508 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2007 | 1397 | 0.080 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5764 | 0.080 |
Why?
|
Albuterol | 1 | 2010 | 213 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 631 | 0.080 |
Why?
|
Erythropoietin | 1 | 2013 | 719 | 0.080 |
Why?
|
Hippocampus | 3 | 2016 | 3755 | 0.080 |
Why?
|
Double-Blind Method | 7 | 2013 | 12320 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2891 | 0.080 |
Why?
|
Demography | 2 | 2013 | 1648 | 0.080 |
Why?
|
Disabled Persons | 2 | 2013 | 1224 | 0.080 |
Why?
|
Risk Factors | 12 | 2019 | 74055 | 0.080 |
Why?
|
Fuzzy Logic | 1 | 2007 | 57 | 0.070 |
Why?
|
Peptides | 2 | 2010 | 4338 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2009 | 504 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4168 | 0.070 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2009 | 326 | 0.070 |
Why?
|
Reference Values | 5 | 2009 | 4921 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2009 | 1066 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 1975 | 0.070 |
Why?
|
Blood-Brain Barrier | 4 | 2015 | 1024 | 0.070 |
Why?
|
Preoperative Care | 1 | 2016 | 2242 | 0.070 |
Why?
|
Gene Frequency | 2 | 2010 | 3637 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2006 | 2531 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 628 | 0.070 |
Why?
|
Verbal Learning | 2 | 2009 | 463 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3510 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2013 | 5236 | 0.060 |
Why?
|
Recurrence | 4 | 2021 | 8466 | 0.060 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2005 | 11 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2975 | 0.060 |
Why?
|
Time | 1 | 2007 | 544 | 0.060 |
Why?
|
Observer Variation | 3 | 2018 | 2604 | 0.060 |
Why?
|
Time Factors | 11 | 2020 | 39947 | 0.060 |
Why?
|
Vaccines, Subunit | 1 | 2005 | 161 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 898 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1004 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3904 | 0.060 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 40 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4026 | 0.060 |
Why?
|
Electromagnetic Fields | 1 | 2006 | 296 | 0.060 |
Why?
|
Perfusion | 1 | 2009 | 1374 | 0.060 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2852 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1582 | 0.060 |
Why?
|
Quality of Life | 2 | 2017 | 13338 | 0.060 |
Why?
|
Calibration | 1 | 2006 | 818 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2005 | 623 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2626 | 0.060 |
Why?
|
beta-Lactams | 1 | 2005 | 157 | 0.060 |
Why?
|
Adolescent | 14 | 2016 | 88196 | 0.050 |
Why?
|
Dyspnea | 1 | 2011 | 1344 | 0.050 |
Why?
|
Apolipoprotein E4 | 1 | 2008 | 706 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2005 | 237 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2878 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1533 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2633 | 0.050 |
Why?
|
Alleles | 2 | 2010 | 6908 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 1896 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 172 | 0.050 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2005 | 343 | 0.050 |
Why?
|
Logistic Models | 6 | 2017 | 13240 | 0.050 |
Why?
|
Pilot Projects | 4 | 2022 | 8611 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2166 | 0.050 |
Why?
|
Information Dissemination | 2 | 2021 | 1127 | 0.050 |
Why?
|
Linear Models | 4 | 2018 | 5865 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2004 | 490 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3302 | 0.050 |
Why?
|
Placebos | 2 | 2021 | 1661 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2420 | 0.050 |
Why?
|
Smoking | 2 | 2009 | 9046 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3457 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2009 | 1409 | 0.050 |
Why?
|
Monocytes | 2 | 2013 | 2572 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2005 | 363 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2691 | 0.050 |
Why?
|
Prevalence | 3 | 2019 | 15698 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2019 | 64591 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2008 | 953 | 0.050 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2013 | 281 | 0.050 |
Why?
|
Diffusion | 3 | 2015 | 814 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2870 | 0.040 |
Why?
|
Iron | 1 | 2009 | 1787 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2008 | 895 | 0.040 |
Why?
|
Adjuvants, Immunologic | 2 | 2010 | 1035 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4549 | 0.040 |
Why?
|
Hydroxyquinolines | 1 | 1999 | 17 | 0.040 |
Why?
|
Hand | 1 | 2005 | 902 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7380 | 0.040 |
Why?
|
Computer Simulation | 3 | 2009 | 6230 | 0.040 |
Why?
|
Databases as Topic | 1 | 2021 | 473 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2006 | 2711 | 0.040 |
Why?
|
Neurons | 2 | 2022 | 9443 | 0.040 |
Why?
|
Incidence | 4 | 2023 | 21322 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 759 | 0.040 |
Why?
|
Hemoglobin SC Disease | 1 | 1996 | 23 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 626 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1999 | 584 | 0.030 |
Why?
|
Erythrocytes | 2 | 1996 | 2417 | 0.030 |
Why?
|
Bone Marrow | 2 | 1999 | 2907 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 2 | 2006 | 1805 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3418 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3202 | 0.030 |
Why?
|
Laser Therapy | 2 | 1993 | 1092 | 0.030 |
Why?
|
Motor Cortex | 2 | 2003 | 1003 | 0.030 |
Why?
|
Acoustic Stimulation | 3 | 2005 | 1234 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 103 | 0.030 |
Why?
|
Phenotype | 3 | 2013 | 16585 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1125 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6297 | 0.030 |
Why?
|
Hydroxyurea | 1 | 1996 | 282 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2005 | 1795 | 0.030 |
Why?
|
Postural Balance | 1 | 2000 | 621 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1995 | 209 | 0.030 |
Why?
|
Amygdala | 1 | 2003 | 1353 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 4518 | 0.030 |
Why?
|
Meglumine | 1 | 1995 | 145 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1938 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 615 | 0.030 |
Why?
|
Age Factors | 4 | 2013 | 18379 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1995 | 389 | 0.030 |
Why?
|
HIV Infections | 2 | 2011 | 17328 | 0.030 |
Why?
|
Phorbol Esters | 1 | 2013 | 108 | 0.030 |
Why?
|
Glioblastoma | 2 | 2019 | 3481 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5662 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1887 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168253 | 0.030 |
Why?
|
Face | 1 | 2019 | 1020 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1336 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1750 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12976 | 0.030 |
Why?
|
Body Fluid Compartments | 1 | 1992 | 50 | 0.030 |
Why?
|
Oxygen | 4 | 2005 | 4222 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 316 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7582 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2006 | 10188 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 1995 | 649 | 0.020 |
Why?
|
Accidental Falls | 1 | 2019 | 1066 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 2 | 2005 | 562 | 0.020 |
Why?
|
Comorbidity | 2 | 2019 | 10494 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3469 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3157 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6471 | 0.020 |
Why?
|
Brain Edema | 1 | 1995 | 604 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 576 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 305 | 0.020 |
Why?
|
Knee Joint | 2 | 1999 | 1673 | 0.020 |
Why?
|
Axons | 1 | 2018 | 1673 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 147 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1571 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 226 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 22097 | 0.020 |
Why?
|
Arginine | 1 | 2013 | 933 | 0.020 |
Why?
|
Sex Factors | 2 | 2007 | 10538 | 0.020 |
Why?
|
Child | 4 | 2013 | 80086 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 1992 | 544 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9533 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 5491 | 0.020 |
Why?
|
Drug Combinations | 1 | 1995 | 2043 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2010 | 344 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30025 | 0.020 |
Why?
|
Lipids | 1 | 1999 | 3342 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2010 | 375 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 410 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11096 | 0.020 |
Why?
|
Somatosensory Cortex | 2 | 2003 | 511 | 0.020 |
Why?
|
Urination | 1 | 2009 | 203 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1487 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 536 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1370 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2009 | 374 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 290 | 0.020 |
Why?
|
Social Behavior | 1 | 2013 | 1132 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10759 | 0.020 |
Why?
|
Entorhinal Cortex | 1 | 2008 | 287 | 0.020 |
Why?
|
Third Ventricle | 1 | 2007 | 74 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 957 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7424 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8826 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1812 | 0.020 |
Why?
|
Attention | 1 | 2016 | 2391 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2006 | 149 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4369 | 0.020 |
Why?
|
Immunologic Tests | 1 | 2006 | 103 | 0.020 |
Why?
|
Piperacillin | 1 | 2005 | 37 | 0.020 |
Why?
|
Ceftazidime | 1 | 2005 | 57 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 1993 | 916 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 2569 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2012 | 1891 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 1994 | 1872 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18216 | 0.010 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.010 |
Why?
|
Area Under Curve | 1 | 2009 | 1633 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 595 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 1998 | 9003 | 0.010 |
Why?
|
Models, Structural | 1 | 2004 | 341 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4277 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2005 | 451 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2007 | 916 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10180 | 0.010 |
Why?
|
Cephalosporins | 1 | 2005 | 204 | 0.010 |
Why?
|
Amoxicillin | 1 | 2005 | 180 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 965 | 0.010 |
Why?
|
Body Water | 2 | 1995 | 340 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2723 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22121 | 0.010 |
Why?
|
Odds Ratio | 2 | 2010 | 9639 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 664 | 0.010 |
Why?
|
Immune System | 1 | 2008 | 794 | 0.010 |
Why?
|
Mathematics | 1 | 2004 | 707 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2642 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2009 | 1115 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 981 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2846 | 0.010 |
Why?
|
Rotation | 1 | 2004 | 517 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1874 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4849 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15867 | 0.010 |
Why?
|
Individuality | 1 | 2004 | 300 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4777 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4355 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 819 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2927 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15476 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3329 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 6215 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2518 | 0.010 |
Why?
|
Dichotic Listening Tests | 1 | 2001 | 22 | 0.010 |
Why?
|
Cause of Death | 1 | 2011 | 3686 | 0.010 |
Why?
|
Hemodynamics | 1 | 2011 | 4167 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7230 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 506 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3445 | 0.010 |
Why?
|
Phantoms, Imaging | 2 | 1999 | 2522 | 0.010 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2000 | 91 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1998 | 9267 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3685 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2053 | 0.010 |
Why?
|
Cues | 1 | 2005 | 874 | 0.010 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 253 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20551 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8522 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2004 | 708 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6963 | 0.010 |
Why?
|
Memory | 1 | 2009 | 2182 | 0.010 |
Why?
|
Software Design | 1 | 1999 | 171 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9326 | 0.010 |
Why?
|
United States | 2 | 2018 | 72202 | 0.010 |
Why?
|
Spin Labels | 1 | 1999 | 338 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1998 | 228 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4567 | 0.010 |
Why?
|
Glioma | 1 | 1993 | 3434 | 0.010 |
Why?
|
Erythrocyte Aggregation | 1 | 1996 | 35 | 0.010 |
Why?
|
Movement | 1 | 2003 | 1478 | 0.010 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 1996 | 150 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12969 | 0.010 |
Why?
|
Arousal | 1 | 2001 | 1162 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 1996 | 201 | 0.010 |
Why?
|
Triethyltin Compounds | 1 | 1995 | 4 | 0.010 |
Why?
|
Ion Transport | 1 | 1996 | 319 | 0.010 |
Why?
|
Language | 1 | 2005 | 1537 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11900 | 0.010 |
Why?
|
Hydrogen | 1 | 1996 | 172 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12054 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 1859 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81402 | 0.010 |
Why?
|
Intraoperative Care | 1 | 1998 | 766 | 0.010 |
Why?
|
Hematocrit | 1 | 1996 | 625 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 42209 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2001 | 1420 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12429 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1996 | 345 | 0.010 |
Why?
|
Functional Laterality | 1 | 2001 | 2253 | 0.010 |
Why?
|
Extracellular Space | 1 | 1996 | 563 | 0.010 |
Why?
|
Water | 1 | 2000 | 1409 | 0.010 |
Why?
|
Chlorides | 1 | 1996 | 665 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1999 | 1703 | 0.010 |
Why?
|
PUVA Therapy | 1 | 1993 | 101 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2005 | 3822 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2005 | 5105 | 0.010 |
Why?
|
Lung | 1 | 2011 | 9973 | 0.010 |
Why?
|
Potassium | 1 | 1996 | 1311 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6168 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3800 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1993 | 825 | 0.010 |
Why?
|
Triglycerides | 1 | 1999 | 2458 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10698 | 0.010 |
Why?
|
Laser Coagulation | 1 | 1993 | 330 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12653 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23397 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1996 | 3088 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12785 | 0.010 |
Why?
|
Forecasting | 1 | 1999 | 2925 | 0.010 |
Why?
|
Hypothalamus | 1 | 1995 | 999 | 0.010 |
Why?
|
Neural Pathways | 1 | 2001 | 3049 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 1524 | 0.010 |
Why?
|
Radiosurgery | 1 | 1998 | 1341 | 0.000 |
Why?
|
Rabbits | 1 | 1995 | 4780 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1997 | 6019 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1994 | 2416 | 0.000 |
Why?
|
Fatty Acids | 1 | 1994 | 1805 | 0.000 |
Why?
|
Lipid Metabolism | 1 | 1994 | 1899 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4430 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 7996 | 0.000 |
Why?
|
Rats | 1 | 1993 | 23712 | 0.000 |
Why?
|